PMID: 2106384Mar 15, 1990Paper

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence

Cancer
J H BrämswigG Schellong

Abstract

Testicular function was evaluated in 75 boys after treatment for Hodgkin's disease with involved-field or extended-field irradiation and stage-dependent chemotherapy (vincristine, prednisone, procarbazine, Adriamycin [doxorubicin], and cyclophosphamide [OPPA/COPP]). Although pubertal development and testosterone levels were normal in all patients, 18 of 75 (24.0%) had elevated basal and 65/74 (87.8%) elevated stimulated luteinizing hormone (LH) levels, demonstrating chemotherapy-induced Leydig cell damage. In addition, there was a 40.5% and 53.4% incidence of elevated basal and stimulated FSH values, respectively, indicating severe impairment of spermatogenesis as confirmed by azoospermia in four patients. Testicular dysfunction was observed in patients treated before as well as during puberty. The incidence of elevated basal follicle stimulating hormone (FSH) and LH values was significantly higher in patients who had received higher cumulative doses of chemotherapy, i.e., 28.9% and 13.2% with two OPPA, 45.5% and 36.4% with two OPPA/two COPP, and 62.5% and 43.8% with two OPPA/four to six COPP, respectively. Chemotherapy for Hodgkin's disease causes a high and apparently dose-related incidence of testicular dysfunction in prepub...Continue Reading

References

Jun 1, 1978·Australian and New Zealand Journal of Medicine·H P RoeserA J Smith
Jan 1, 1977·International Journal of Radiation Oncology, Biology, Physics·J SlaninaR Stiasny
Feb 1, 1979·Fertility and Sterility·A C HsuC P Rance
Aug 1, 1976·Scandinavian Journal of Haematology·G AsbjornsenA Aakvaag
May 1, 1986·Annals of Internal Medicine·M R MacAdamsB E Chipps
Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·E D KreuserH Heimpel
Apr 8, 1988·JAMA : the Journal of the American Medical Association·S A Rivkees, J D Crawford
Apr 1, 1972·The Journal of Clinical Investigation·D H Van ThielV T De Vita
Jan 1, 1972·The Journal of Clinical Endocrinology and Metabolism·J M LeonardC A Paulsen
Sep 1, 1972·The Journal of Clinical Endocrinology and Metabolism·D M De KretserH P Taft
Feb 1, 1970·Archives of Disease in Childhood·W A Marshall, J M Tanner
Jan 1, 1984·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·G BonadonnaG Ragni
Sep 1, 1983·Journal of Andrology·S NaderN A Samaan
Dec 1, 1984·Archives of Disease in Childhood·B RobinsonT J McElwain
Jun 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F da CunhaP G Salvador
Jan 1, 1981·Medical and Pediatric Oncology·D M GreenA I Freeman
Dec 4, 1982·British Medical Journal·J H WaxmanT A Lister

❮ Previous
Next ❯

Citations

Sep 18, 2013·Current Osteoporosis Reports·Carmen L Wilson, Kirsten K Ness
Jan 1, 1994·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T F BergR W Hart
Jan 16, 1999·Pediatric Clinics of North America·M Grossi
May 16, 2003·Current Problems in Cancer·Daniel M Green
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·W J Hrushesky
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·U RühlW Dörffel
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Sarah S Donaldson
Jan 29, 1999·Endocrinology and Metabolism Clinics of North America·S Howell, S Shalet
Sep 1, 1996·Baillière's Clinical Haematology·M Henry-Amar
Sep 24, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P M LähteenmäkiT T Salmi
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R Pötter
Jun 12, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SieniawskiA Engert
Sep 8, 2011·Human Reproduction Update·W van DorpM M van den Heuvel-Eibrink
Aug 1, 1997·American Journal of Clinical Oncology·S S KulkarniS H Advani
Jan 25, 2003·Current Opinion in Pediatrics·Cindy L Schwartz
Oct 8, 1998·British Journal of Obstetrics and Gynaecology·G A Levitt, M E Jenney
Jun 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa B KenneyLillian Meacham
Jan 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Gabriele CalaminusGünther Schellong
Sep 19, 2008·International Urology and Nephrology·Antônio MiragemHelena von Eye Corleta
Dec 9, 2015·Microscopy Research and Technique·Fereshte AliakbariMaryam Baazm
Jun 1, 1995·Medical and Pediatric Oncology·C MustielesR Barrio
Dec 5, 2009·Seminars in Radiation Oncology·Angela PunnettDavid C Hodgson
Aug 4, 2015·Pediatric Blood & Cancer·Amish C ShahMichael J Fisher
Apr 24, 2008·Acta Paediatrica·P M LähteenmäkiJ Toppari
Apr 1, 1992·Surgical Oncology·F E JohnsonK C Tolman
Jun 27, 2007·Seminars in Radiation Oncology·David C HodgsonLouis S Constine
Oct 3, 2013·Journal of Cancer Research and Clinical Oncology·Simone ReinmuthAnja Borgmann-Staudt
Jan 1, 1996·Medical and Pediatric Oncology·S KlieschE Nieschlag
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melissa M HudsonHoward J Weinstein
Nov 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen ToledanoIsaac Yaniv
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine Mauz-KörholzDieter Körholz
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas EngertMarkus Löffler
Sep 1, 1996·European Journal of Pediatrics·H L MüllerJ Kühl
Apr 26, 2000·Pediatric Hematology and Oncology·M W Ben ArushA Kuten
Oct 25, 2000·Hospital Medicine·A B Waring, W H Wallace
Aug 1, 1996·Medical and Pediatric Oncology·E J MackieS M Shalet
Apr 29, 1999·Medical and Pediatric Oncology·V PapadakisC Sklar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.